DREGX | VEMIX | DREGX / VEMIX | |
Total Expense Ratio | 1.22 | 0.09 | 1,356% |
Annual Report Gross Expense Ratio | 1.22 | 0.09 | 1,356% |
Fund Existence | 28 years | 25 years | - |
Gain YTD | 26.004 | 23.160 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 5000000 | 0% |
Min. Initial Investment IRA | 2000 | N/A | - |
Net Assets | 4.02B | 138B | 3% |
Annual Yield % from dividends | 0.71 | 2.82 | 25% |
Returns for 1 year | 20.70 | 17.46 | 119% |
Returns for 3 years | 54.62 | 57.97 | 94% |
Returns for 5 years | 7.26 | 33.50 | 22% |
Returns for 10 years | 75.03 | 77.82 | 96% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IRVAX | 25.96 | 0.14 | +0.54% |
Voya Russell Large Cap Value Idx Port A | |||
ETHSX | 13.32 | 0.07 | +0.53% |
Eaton Vance Worldwide Health Sci A | |||
JMVRX | 37.71 | 0.17 | +0.45% |
JPMorgan Mid Cap Value R5 | |||
PGPCX | 27.98 | 0.09 | +0.32% |
George Putnam Balanced C | |||
OCHIX | 9.83 | -0.08 | -0.81% |
Oberweis China Opportunities Instl |